ATE406885T1 - Nateglinid enthaltende präparate - Google Patents

Nateglinid enthaltende präparate

Info

Publication number
ATE406885T1
ATE406885T1 AT01976817T AT01976817T ATE406885T1 AT E406885 T1 ATE406885 T1 AT E406885T1 AT 01976817 T AT01976817 T AT 01976817T AT 01976817 T AT01976817 T AT 01976817T AT E406885 T1 ATE406885 T1 AT E406885T1
Authority
AT
Austria
Prior art keywords
nateglinide
preparations containing
containing nateglinide
antidiabetic
immediate
Prior art date
Application number
AT01976817T
Other languages
English (en)
Inventor
N Ninomiya
Chisato Makino
Akira Yabuki
Original Assignee
Ajinomoto Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ajinomoto Kk filed Critical Ajinomoto Kk
Application granted granted Critical
Publication of ATE406885T1 publication Critical patent/ATE406885T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT01976817T 2000-10-24 2001-10-23 Nateglinid enthaltende präparate ATE406885T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2000324373 2000-10-24

Publications (1)

Publication Number Publication Date
ATE406885T1 true ATE406885T1 (de) 2008-09-15

Family

ID=18801918

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01976817T ATE406885T1 (de) 2000-10-24 2001-10-23 Nateglinid enthaltende präparate

Country Status (17)

Country Link
US (2) US7605180B2 (de)
EP (1) EP1334720B1 (de)
JP (3) JP4501054B2 (de)
KR (1) KR100869039B1 (de)
CN (1) CN100352432C (de)
AT (1) ATE406885T1 (de)
AU (1) AU2001295999A1 (de)
BR (1) BR0114896A (de)
CA (1) CA2426263C (de)
DE (1) DE60135674D1 (de)
DK (1) DK1334720T3 (de)
ES (1) ES2307653T3 (de)
MX (1) MXPA03003685A (de)
PT (1) PT1334720E (de)
RU (1) RU2271805C2 (de)
TW (1) TWI283573B (de)
WO (1) WO2002034254A1 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2395993A1 (en) * 1999-12-28 2001-07-05 Ajinomoto Co., Inc. Antidiabetic preparation for oral administration
KR20070104953A (ko) * 2000-03-17 2007-10-29 아지노모토 가부시키가이샤 신경 장애용 약제
ATE368641T1 (de) * 2000-10-18 2007-08-15 Ajinomoto Kk Verfahren zur herstellung von nateglinidin- kristallen
CN1273442C (zh) * 2000-10-18 2006-09-06 味之素株式会社 酰基苯丙氨酸的制备方法
MXPA03003685A (es) * 2000-10-24 2004-01-26 Ajinomoto Kk Preparaciones que contienen nateglinida.
AU2001296000A1 (en) * 2000-10-24 2002-05-27 Ajinomoto Co., Inc. Nateglinide-containing hydrophilic drug preparations
RU2275354C2 (ru) * 2000-10-24 2006-04-27 Адзиномото Ко., Инк. Способы получения кристаллов в-типа натеглинида
JP4833464B2 (ja) * 2001-11-28 2011-12-07 大正製薬株式会社 難溶性薬物含有固形製剤の製造方法
US6861553B2 (en) 2002-07-03 2005-03-01 Teva Pharmaceuticals Industries Ltd. Process for preparing nateglinide and intermediates thereof
US7148376B2 (en) 2002-07-18 2006-12-12 Teva Pharmaceutical Industries Ltd. Polymorphic forms of nateglinide
US7534913B2 (en) 2002-07-18 2009-05-19 Teva Pharmaceutica Industries Ltd. Crystalline form of nateglinide
US7358390B2 (en) 2002-07-18 2008-04-15 Teva Pharmaceutical Industries Ltd. Polymorphic forms of nateglinide
US7420084B2 (en) 2002-07-18 2008-09-02 Teva Pharmaceutical Industries Ltd. Polymorphic forms of nateglinide
WO2005013964A1 (ja) 2003-08-08 2005-02-17 Ajinomoto Co., Inc. ナテグリニド含有製剤
WO2005020979A1 (en) * 2003-09-03 2005-03-10 Ranbaxy Laboratories Limited A process for the preparation of pharmaceutical compositions of nateglinide
US20070219250A1 (en) * 2003-11-28 2007-09-20 Romi Singh Pharmaceutical Compositions of Nateglinide
JP5168712B2 (ja) * 2004-04-01 2013-03-27 味の素株式会社 ナテグリニド含有製剤
JP5551852B2 (ja) * 2004-08-10 2014-07-16 味の素株式会社 苦味の低減したナテグリニド含有製剤
WO2006080524A1 (ja) * 2005-01-31 2006-08-03 Ajinomoto Co., Inc. 血糖降下剤を含有する、耐糖能異常、境界型糖尿病、インスリン抵抗性及び高インスリン血症の改善ないし治療用医薬組成物
DE102005047561A1 (de) * 2005-10-04 2007-04-05 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung
NZ597109A (en) 2007-03-29 2013-01-25 Daiichi Sankyo Co Ltd Tablet composition having favorable dissolution property useful as an anticoagulant
TR200801178A2 (tr) * 2008-02-22 2009-09-23 Bi̇li̇m İlaç Sanayi̇ Ti̇caret A.Ş. Nateglinid ve surfaktan-ph ayarlayıcı sistemi içeren oral tablet kompozisyonları
CN101590063A (zh) * 2008-05-26 2009-12-02 中国科学院上海生命科学研究院 丹参酮iia在制备治疗肥胖及胰岛素抵抗的药物中的应用
JP5390014B2 (ja) 2010-03-19 2014-01-15 第一三共株式会社 抗凝固剤の溶出改善方法
AU2011266820A1 (en) 2010-06-14 2013-01-24 Cipla Limited A process for the preparation of nateglinide
ES2673182T3 (es) 2011-08-10 2018-06-20 Daiichi Sankyo Company, Limited Composición farmacéutica que contiene un derivado de diamina
CN102813636B (zh) * 2012-08-28 2014-04-16 西南药业股份有限公司 那格列奈片及其制备方法
AU2014295137B2 (en) * 2013-07-22 2019-01-17 Sandoz Ag Formulations containing amorphous dapagliflozin
ES3063790T3 (en) 2015-06-09 2026-04-20 Lonza Sales Ag Formulations to achieve rapid dissolution of drug from spray-dried dispersions in capsules
JP6647902B2 (ja) * 2015-10-30 2020-02-14 株式会社ファンケル 徐放性顆粒剤
KR20240025990A (ko) * 2022-08-19 2024-02-27 주식회사 스카이테라퓨틱스 무정형 수니티닙, 그 제조방법 및 이를 포함한 의약 조성물

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56110612A (en) * 1980-02-08 1981-09-01 Yamanouchi Pharmaceut Co Ltd Readily disintegrable and absorbable compression molded article of slightly soluble drug
FR2525108B1 (fr) * 1982-04-19 1989-05-12 Elan Corp Ltd Medicaments a haut degre de solubilite et procede pour leur obtention
JPH0249720A (ja) * 1988-05-18 1990-02-20 Mitsubishi Kasei Corp 難溶性薬剤組成物
US5041232A (en) * 1990-03-16 1991-08-20 Lever Brothers Company, Division Of Conopco, Inc. Sulfonimines as bleach catalysts
JPH0415221A (ja) 1990-05-08 1992-01-20 Daicel Chem Ind Ltd ポリカーボネートの製造法
US5232735A (en) * 1990-06-01 1993-08-03 Bioresearch, Inc. Ingestibles containing substantially tasteless sweetness inhibitors as bitter taste reducers or substantially tasteless bitter inhibitors as sweet taste reducers
US5463116A (en) * 1991-07-30 1995-10-31 Ajinomoto Co., Inc. Crystals of N- (trans-4-isopropylcyclohexlycarbonyl)-D-phenylalanine and methods for preparing them
ES2100291T3 (es) * 1991-07-30 1997-06-16 Ajinomoto Kk Cristales de n-(trans-4-isopropilciclohexilcarbonil)-d-fenilalanina y metodos para prepararlos.
ATE503472T1 (de) 1996-11-15 2011-04-15 Ajinomoto Kk Nateglinide-tablettenzubereitungen
TW486370B (en) * 1996-12-25 2002-05-11 Yamanouchi Pharma Co Ltd Rapidly disintegrable pharmaceutical composition
ATE429210T1 (de) * 1998-01-20 2009-05-15 Applied Analytical Ind Inc Orale flüssige zusammensetzungen
US6559188B1 (en) * 1999-09-17 2003-05-06 Novartis Ag Method of treating metabolic disorders especially diabetes, or a disease or condition associated with diabetes
CA2395993A1 (en) 1999-12-28 2001-07-05 Ajinomoto Co., Inc. Antidiabetic preparation for oral administration
KR20070104953A (ko) 2000-03-17 2007-10-29 아지노모토 가부시키가이샤 신경 장애용 약제
ATE368641T1 (de) 2000-10-18 2007-08-15 Ajinomoto Kk Verfahren zur herstellung von nateglinidin- kristallen
CN1273442C (zh) 2000-10-18 2006-09-06 味之素株式会社 酰基苯丙氨酸的制备方法
AU2001296000A1 (en) 2000-10-24 2002-05-27 Ajinomoto Co., Inc. Nateglinide-containing hydrophilic drug preparations
RU2275354C2 (ru) 2000-10-24 2006-04-27 Адзиномото Ко., Инк. Способы получения кристаллов в-типа натеглинида
MXPA03003685A (es) * 2000-10-24 2004-01-26 Ajinomoto Kk Preparaciones que contienen nateglinida.
US6830759B2 (en) 2002-06-28 2004-12-14 Ajinomoto Co., Inc. Antidiabetic preparation for oral administration
WO2005013964A1 (ja) * 2003-08-08 2005-02-17 Ajinomoto Co., Inc. ナテグリニド含有製剤

Also Published As

Publication number Publication date
JPWO2002034254A1 (ja) 2004-08-26
JP5610165B2 (ja) 2014-10-22
EP1334720A1 (de) 2003-08-13
KR20030042027A (ko) 2003-05-27
PT1334720E (pt) 2008-09-30
DE60135674D1 (de) 2008-10-16
JP2010100654A (ja) 2010-05-06
CA2426263C (en) 2010-05-25
US7605180B2 (en) 2009-10-20
JP2013028636A (ja) 2013-02-07
MXPA03003685A (es) 2004-01-26
KR100869039B1 (ko) 2008-11-17
CA2426263A1 (en) 2003-04-23
CN1482903A (zh) 2004-03-17
RU2271805C2 (ru) 2006-03-20
ES2307653T3 (es) 2008-12-01
EP1334720A4 (de) 2004-02-04
DK1334720T3 (da) 2009-01-19
JP4501054B2 (ja) 2010-07-14
CN100352432C (zh) 2007-12-05
US20090203791A1 (en) 2009-08-13
TWI283573B (en) 2007-07-11
WO2002034254A1 (fr) 2002-05-02
US20040014815A1 (en) 2004-01-22
BR0114896A (pt) 2003-08-12
AU2001295999A1 (en) 2002-05-06
EP1334720B1 (de) 2008-09-03

Similar Documents

Publication Publication Date Title
ATE406885T1 (de) Nateglinid enthaltende präparate
NZ527032A (en) Isoxazoline derivative and herbicide containing the same as the active ingredient
NO20034149L (no) Legemidler inneholdende triazaspiro[5.5]undekanderivater som den aktive bestanddel
NO20016107L (no) Mesalazin-kontrollert frigivelse orale farmasöytiske sammensetninger
HUP0101237A1 (hu) Elnyújtott kioldódású gyógyszerkészítmények
NO20026037L (no) Sötvareprodukt som inneholder aktive bestanddeler
DK1300398T3 (da) Propan-1,3-dionderivat
USD456051S1 (en) Exercise device
DK1389213T3 (da) 3,7-Diazabicyclo[3.3.1]formuleringer som antiarytmiske forbindelser
DK1330458T3 (da) N-(1,2,4-triazoloazinyl)thiophensulfonamidforbindelser som herbicider
ITMI20000440A0 (it) Forme solide orali a rilascio controllato contenenti mesalazina come principio attivo
ZA200304928B (en) Medicament containing a polyamine as an active substance.
EP1026162A4 (de) Antirheumatika
ATE365734T1 (de) Herbizide furanyl- und thienyloxyazine
NO913019L (no) Faste orale preparatformer som inneholder ifosfamid som virksomt stoff.
NO20034528D0 (no) 3,7-diazabicyklo(3,3,1) formuleringer som antiarytmiforbindelser
RU2000118409A (ru) Антимутагенное средство
NO20041878L (no) Karboksylsyrederivat-forbindelser og legemidler inneholdende de samme som den aktive bestanddel.
EP0729950A4 (de) Anti-hiv arzneimittel
WO2002024210A3 (en) Halogen compounds for use in medicine
ITMI20000972A0 (it) Formulazioni farmaceutiche, a rilascio modificato, con elevata biodisponibilita', contenenti principi attivi ad attivita' antibiotica.
Fitzerald Guilty until proven innocent
AU2002235794B2 (en) Medicament containing a polyamine as an active substance
AU2002235794A1 (en) Medicament containing a polyamine as an active substance
AU2002340471A1 (en) Storage stable thyroxine active drug formulations

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1334720

Country of ref document: EP